Translational trendspotting: a Distillery dive into cancer

Innovations in cancer are yielding new targets backed by biomarkers, protein degrader compounds and strategies to boost T cell activity, according to trends emerging from BioCentury’s Distillery. 

BioCentury’s Distillery, a curated collection of top translational studies in the scientific literature, provides summaries of preclinical papers showing innovative interventions with disease-modifying effects, and highlights the investigators moving the ball forward, along with the status of their IP at the time of publication. ...